Heading to Washington DC for @AASLDtweets #TLM2025 ! A great opportunity to connect with peers, exchange ideas, and advance liver disease research! See you in DC Nov 7-11! #Livertwitter @RoyAHep @ajay_duseja @drsuniltaneja @AnandVKulkarni2 @ebtapper @DrArunKValsan @drbabupgi

📢Autoantibodies matter in #MASLD Global study of 460 biopsy-proven cases, ANA or ASMA positivity independently predicted: ⚠️ 3.9× higher risk of liver decomp ⚰️ 2.5× higher risk of death 📉 Histologic AIH features didn’t correlate with outcomes 👉 https://t.co/kxeEaeoVI1

🎓✨ Proud Moment! Our PhD student @pinderbrar888 , has successfully defended her thesis in the public viva with flying colors! 🌟👏 A milestone for her and our team. 🚀💡 Huge gratitude to super mentors @ajay_duseja @drsuniltaneja drvirendrasingh @RajivJalan1 @INASL_Liver

Humbled to receive the AIG-Crystal-Distinguished Leadership Award Thanks to @DrDNReddy @gvraoaig, Dr PN Rao, Dr Mithun, @AnandVKulkarni2 @manasa_alla and AIG team @AIGHospitals Owe it to my family @RitambhraN, department @HepatologyPGI, Institute @dpgi_chandigarh and @INASL_Liver

#WATCH | Dubai's Burj Khalifa illuminated tonight with the images of PM Narendra Modi, on the occasion of his 75th birthday.

#APASL guidelines on management of acute variceal bleeding are out🚨 Glad to have participated in drafting the section on “Role of endoscopy in AVB” Special thanks to Prof @drshivsarin for the opportunity, Prof #RinaldiLesmana for the excellent leadership, and kudos to the

@INASL_Liver hosted Global NASH Council meeting. Presented data on prevention & control #PreventiveHepatology of MASLD in South Asia. Congratulations @ajay_duseja @ZobairYounossi  for initiating South Asia Registry @aiimsrishi @EASLnews @LiverSaver @WHO @SagiZelber @MoHFW_INDIA

🚨 FDA approves Wegovy® (semaglutide) for MASH w/ moderate–advanced fibrosis (non-cirrhotic). ⚠️Watch for GI side-effects, especially pancreas & gallbladder risks. 👉Use only under expert care. Confirmatory trials are ongoing. #FDA #Wegovy #MASH #GLP1 🔗

INASL-2025 Chandigarh One week over, but the hangover continues. This was like once in a lifetime event. Hard work of almost 2 years by the team. Thanks to my family and colleagues. Big thanks to the faculty, delegates, and all the contributors. Long live INASL @INASL_Liver

Now @JCEH_Hepatology IGB for MASLD/MASH. The future is a combination of anti-fibrotic agents and weight loss remedies.

🚩NOT only a novel prognostic index in acutely decompensated cirrhosis.. 📍Our study identifying novel therapeutic targets in AD and ACLF @HepatologyPGI @ajay_duseja @drsuniltaneja in collaboration with @ucl @RajivJalan1 Berlin Cornelius 🎯 RIPK3 🎯 https://t.co/A08KieGavj

🇮🇳 #INASL2025 🌐 Science beyond institutions 😇 mentors @ajay_duseja @drsuniltaneja 🤝 GNC meet 🤖 AI workshop 📚30+presentations @HepatologyPGI 🦠 Infections 📊 Research workshop 🏆 Plenary award 🎉 Governing Council Membership🙏 🌍 One world🔗One force 🏹 liver Ds 💪

@Manumehta90 @ajay_duseja @drnipunverma @doc_arka @drsuniltaneja @DrMPK @naveendandia @drbabupgi Congratulations 🎉🎊

@INASL_Liver 2025 at #PGIMER Chandigarh concluded today on a high note. ✅ Insightful lectures ✅ Engaging interactions with stalwarts of Hepatology ✅Endo-hepatology, POCUS, AI workshops ✅ Inspiring plenary and young investigator sessions A heartfelt thanks to @ajay_duseja

Had an incredible experience at #INASL 2025, honoured to win 3rd poster presidential award. Grateful to my guide @ajay_duseja and my mentors @drnipunverma , @doc_arka , @drsuniltaneja , @DrMPK ,@naveendandia and @drbabupgi for their constant support.

Prof YK Chawla Pioneer of Hepatology in India delivered the powerful B N Tandon Memorial oration, celebrating the remarkable journey and groundbreaking evolution of Hepatology in India—a truly outstanding achievement!@INASL_Liver @ajay_duseja @AASLDtweets @EASLnews

Symposium on Ascites/AKI at @INASL_Liver — talks by Dr Gaurav Pande, Dr Rakhi Maiwall & Dr Virendra Singh on SBP prophylaxis, challenges & perspectives. #Hepatology

Insightful session by Prof Richard S. Finn on ‘Maximizing Patient Outcomes in Unresectable HCC’-covering evolving systemic therapies, combination strategies & personalized care. @INASL_Liver #LiverCancer #HCC

Session by Prof Sanjeeva Kalva on a multimodality approach to liver tumors-expertly covering imaging, intervention & integrated management. #LiverCancer #Hepatology @INASL_Liver

Debate at @INASL_Liver on the role of ammonia in cirrhosis — is it a true guide for diagnosis & management or just a lab value? Prof Akash Shukla & Prof Rajiv Jalan in an insightful face-off. #Hepatology #Cirrhosis